X

Vous n'êtes pas connecté

  - DRUGS.COM - Pharma Industry News - 29/Aug 15:08

Older Age, Lower Fitness Linked to Atrial Ectopic Burden

FRIDAY, Aug. 29, 2025 -- Age is a significant independent risk factor for atrial ectopic burden (AEB) and ventricular ectopic burden (VEB), according to a study presented at the European Society of Cardiology Congress 2025, held from Aug. 29 to...

Articles similaires

Sorry! Image not available at this time

Older Age, Lower Fitness Linked to Atrial Ectopic Burden

drugs.com - 29/Aug 15:08

FRIDAY, Aug. 29, 2025 -- Age is a significant independent risk factor for atrial ectopic burden (AEB) and ventricular ectopic burden (VEB), according...

Sorry! Image not available at this time

Cytokinetics Presents New Data Related to Aficamten at the European Society of Cardiology Congress 2025

mangaloremirror.com - 31/Aug 16:54

Additional Data from MAPLE-HCM Shows Aficamten Improves Cardiac Structure and Function Compared to Metoprolol; Simultaneous Publication in the...

Older age and low fitness identified as independent risk factors for heart rhythm disorders

news.medical.net - 28/Aug 03:48

New research has revealed that older age and low aerobic fitness levels are strong and independent risk factors for a high burden of heartbeat...

Sorry! Image not available at this time

Diabetes Risk Commonly Clustered Within Households

drugs.com - 19/Aug 15:08

TUESDAY, Aug. 19, 2025 -- Diabetes risk is commonly clustered within households, according to a study scheduled to be presented at the annual meeting...

Sorry! Image not available at this time

Diabetes Risk Commonly Clustered Within Households

drugs.com - 19/Aug 15:08

TUESDAY, Aug. 19, 2025 -- Diabetes risk is commonly clustered within households, according to a study scheduled to be presented at the annual meeting...

Sorry! Image not available at this time

Cytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine

mangaloremirror.com - 30/Aug 07:55

Positive Trial Demonstrates Superiority of Aficamten to Standard-of-Care Beta-Blocker Metoprolol Primary Endpoint Result Consistent Across All...

Sorry! Image not available at this time

Cytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine

mangaloremirror.com - 30/Aug 07:55

Positive Trial Demonstrates Superiority of Aficamten to Standard-of-Care Beta-Blocker Metoprolol Primary Endpoint Result Consistent Across All...

Sorry! Image not available at this time

Genentech and Alnylam Advance Zilebesiran Into Global Phase III Cardiovascular Outcomes Trial for People With Uncontrolled Hypertension

wn.com - 30/Aug 19:42

– Phase III trial informed by comprehensive KARDIA data set generated through three Phase II studies: KARDIA-1, KARDIA-2 and KARDIA-3 – – In...

Sorry! Image not available at this time

Type of Hormone Therapy Used After Menopause Affects Memory Performance

drugs.com - 29/Aug 15:08

FRIDAY, Aug. 29, 2025 -- Earlier age at menopause is associated with lower scores on all cognitive domains, and menopausal hormone therapy (MHT)...

Sorry! Image not available at this time

Type of Hormone Therapy Used After Menopause Affects Memory Performance

drugs.com - 29/Aug 15:08

FRIDAY, Aug. 29, 2025 -- Earlier age at menopause is associated with lower scores on all cognitive domains, and menopausal hormone therapy (MHT)...